Sign Up to like & get
recommendations!
0
Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-3525
Abstract: Conventional therapies produce a high rate of cure for patients with localized prostate cancer (PCa), but there is no effective treatment for castration resistant metastatic PCa. Transcription factors by association with enhancer and super-enhancer elements…
read more here.
Keywords:
luminal epithelial;
pdef;
twist1;
differentiation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Reproduction"
DOI: 10.1530/rep-16-0494
Abstract: There are five peptidylarginine deiminase (PAD) isozymes designated as PADs 1, 2, 3, 4 and 6, and many are expressed in female reproductive tissues. These enzymes post-translationally convert positively charged arginine amino acids into neutral…
read more here.
Keywords:
epithelial cells;
citrullination;
luminal epithelial;
insulin like ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pesticide biochemistry and physiology"
DOI: 10.2139/ssrn.4224531
Abstract: Aclonifen is a diphenyl-ether herbicide that is used to control the growth of weeds while growing crops such as corn and wheat. Although the biochemical effects of aclonifen are well characterized, including its ability to…
read more here.
Keywords:
luminal epithelial;
development;
aclonifen;
implantation ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pesticide biochemistry and physiology"
DOI: 10.2139/ssrn.4267747
Abstract: Tebufenpyrad is classified as a pyrazole acaricide and insecticide. It is widely used for several crops, especially in greenhouses, in several countries. While its unfavorable effects on non-target organisms have already been established, relatively little…
read more here.
Keywords:
tebufenpyrad;
luminal epithelial;
cell cycle;
cycle arrest ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.991368
Abstract: The use of immune adjuvants such as toll-like receptor (TLR) agonists reflects a novel strategy in prostate cancer (PCa) therapy. However, interleukin-1 receptor associated kinase 1 (IRAK1), a central effector of TLR signaling, has been…
read more here.
Keywords:
luminal epithelial;
pca;
expression;
receptor associated ... See more keywords